Case Studies Assessing Platelet Availability from Blood Center and Hospital Perspectives
Inventory management for platelet components and fibrinogen sources (such as cryoprecipitated Antihemophilic Factor, or cryo AHF) can be challenging given their short shelf-life. Timely administration of platelets and fibrinogen are essential to prevent delays in treatments and surgeries. This workshop describes how Pathogen Reduced Platelets (also known as INTERCEPT® Platelets) and Pathogen Reduced Cryoprecipitated Fibrinogen Complex (also known as INTERCEPT® Fibrinogen Complex) improve blood availability for patients in need.
Houston “Buddy” Nguyen, BSCLS, MT (ASCP), BIT
Director, Hospital Engagement and Education